呼吸器疾患検査の世界市場レポート 2025年

呼吸器疾患検査の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.6％で46億6,000万米ドルに成長します。予測期間の成長は、空気感染呼吸器ウイルスの増加、在宅検査ソリューションへの注目、精密医療における調査の増加、継続的な環境衛生への懸念、早期介入と予防への注目などに起因しています。予測期間における主な動向には、ポイントオブケア検査、人工知能（AI）の統合、遠隔モニタリング技術、遠隔医療サービス、カスタマイズされたバイオマーカーパネル、呼気分析技術の強化などがあります。

呼吸器疾患の有病率は上昇傾向にあり、当面の呼吸器疾患検査市場を大きく押し上げる見通しです。呼吸器疾患には、肺、気管支、気管、喉頭、咽頭、鼻腔などの呼吸器系に影響を及ぼす病状が含まれます。呼吸器疾患検査の主な目的は、早期発見と診断、そして迅速な治療と管理です。この積極的なアプローチは、疾患の進行を妨げるだけでなく、感染性呼吸器疾患のトランスミッションを制御し、合併症のリスクを低減するためにも極めて重要です。例えば、2022年9月にNCD Allianceが発表したデータによると、肺がんは世界のがん死亡原因の第1位であり、年間220万人が新たに罹患し、180万人が死亡すると予測されています。慢性呼吸器疾患は、世界で5億5,000万人の成人が罹患し、420万人が死亡し、全体の7％を占めています。したがって、呼吸器疾患の有病率の上昇は、呼吸器疾患検査市場の主要な促進要因です。

タバコの喫煙率の増加は、今後の呼吸器疾患検査市場の成長を後押しすると予想されます。タバコ喫煙は、タバコ植物（Nicotiana tabacum）の乾燥した葉を燃焼させ、発生する煙を吸引します。呼吸器疾患検査はタバコ喫煙者の健康管理に不可欠であり、肺機能の経時的変化をモニターすることで、ヘルスケア専門家は禁煙イニシアチブの成功を評価し、それに応じて治療計画を修正することができます。例えば、2024年9月、米国の政府機関である疾病対策予防センター（Centers for Disease Control and Prevention）は、タバコの使用が依然として米国における予防可能な病気と死亡の主な原因であると報告しました。2022年には、成人の約4,920万人、19.8％、ほぼ5人に1人がタバコ製品を使用していることを示しました。その結果、タバコの喫煙率の上昇が呼吸器疾患検査市場の拡大を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の呼吸器疾患検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の呼吸器疾患検査市場：成長率分析
• 世界の呼吸器疾患検査市場の実績：規模と成長, 2019-2024
• 世界の呼吸器疾患検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界の呼吸器疾患検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の呼吸器疾患検査市場：検査タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像検査
• 機械検査
• 体外診断検査
• 世界の呼吸器疾患検査市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肺容量
• イメージング
• スパイロメトリー
• ピークフロー
• 血液ガス
• その他の製品
• 世界の呼吸器疾患検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 慢性閉塞性肺疾患
• 肺がん
• 喘息
• 結核女性
• その他のアプリケーション
• 世界の呼吸器疾患検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 医師の診療所
• 臨床検査室
• その他のエンドユーザー
• 世界の呼吸器疾患検査市場、タイプ別サブセグメンテーション：画像検査、実績と予測, 2019-2024, 2024-2029F, 2034F
• X線
• コンピュータ断層撮影（CT）スキャン
• 磁気共鳴画像（MRI）
• 陽電子放出断層撮影（PET）スキャン
• 世界の呼吸器疾患検査市場、タイプ別サブセグメンテーション：機械検査、実績と予測, 2019-2024, 2024-2029F, 2034F
• スパイロメトリー
• ピークフロー測定
• 肺容量測定
• 拡散能力試験
• 世界の呼吸器疾患検査市場、タイプ別サブセグメンテーション：体外診断検査、実績と予測, 2019-2024, 2024-2029F, 2034F
• PCR検査
• 抗原検査
• 抗体検査
• 培養検査

第7章 地域別・国別分析

• 世界の呼吸器疾患検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の呼吸器疾患検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 呼吸器疾患検査市場：競合情勢
• 呼吸器疾患検査市場：企業プロファイル
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • ResMed Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Thermo Fisher Scientific Inc.
• Becton Dickinson and Company
• F. Hoffmann-La Roche Ltd.
• Nihon Kohden Corporation
• GE HealthCare Technologies Inc.
• Fisher & Paykel Healthcare Corporation Limited
• Qiagen N.V.
• Medical Graphics Corporation
• COSMED srl
• ndd Medizintechnik AG
• Vitalograph Ltd.
• MGC Diagnostics Corporation
• Vyaire Medical Inc.
• Masimo Corporation
• Hamilton Medical AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 呼吸器疾患検査市場2029：新たな機会を提供する国
• 呼吸器疾患検査市場2029：新たな機会を提供するセグメント
• 呼吸器疾患検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Respiratory disease testing encompasses the diagnostic process of evaluating various respiratory conditions through physical examinations. This procedure aids in the identification and measurement of lung conditions, assessing the speed at which a patient can exhale air. The results of these tests can assist clinicians in diagnosing respiratory diseases, even before patients exhibit symptoms.

The primary categories of tests involved in respiratory disease testing include imaging tests, mechanical tests, and in-vitro diagnostic tests. Imaging tests constitute a subset of diagnostic procedures that generate detailed images of various bodily regions. These tests utilize products such as lung volume imaging, spirometry, peak flow, blood gas, among others. They find applications in various respiratory conditions such as chronic obstructive pulmonary disease, lung cancer, asthma, and tuberculosis. These tests are typically conducted in hospitals, physician clinics, clinical laboratories, and other healthcare settings.

The respiratory disease testing market research report is one of a series of new reports from The Business Research Company that provides respiratory disease testing market statistics, including respiratory disease testing industry global market size, regional shares, competitors with a respiratory disease testing market share, detailed respiratory disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disease testing industry. This respiratory disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory disease testing market size has grown steadily in recent years. It will grow from$3.6 billion in 2024 to $3.75 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to environmental factors and pollution, tobacco smoking epidemic, occupational respiratory hazards, awareness and health education programs, government initiatives for disease control

The respiratory disease testing market size is expected to see strong growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to rise in airborne respiratory viruses, focus on home-based testing solutions, increased research in precision medicine, continued environmental health concerns, focus on early intervention and prevention. Major trends in the forecast period include point-of-care testing, integration of artificial intelligence (ai), remote monitoring technologies, telehealth services, customized biomarker panels, enhanced breath analysis techniques.

The upward trajectory in the prevalence of respiratory diseases is poised to significantly boost the respiratory disease testing market in the foreseeable future. Respiratory diseases encompass medical conditions affecting the respiratory system, including the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The primary purpose of respiratory disease testing is early detection and diagnosis, facilitating prompt treatment and management. This proactive approach not only helps impede disease progression but is also crucial for controlling the transmission of infectious respiratory diseases and reducing the risk of complications. For instance, in September 2022, data from the NCD Alliance revealed that lung cancer ranked as the leading cause of global cancer deaths, with an anticipated 2.2 million new cases and 1.8 million fatalities annually. Chronic respiratory disorders affected 550 million adults globally, resulting in 4.2 million deaths, accounting for 7% of the total. Therefore, the rising prevalence of respiratory diseases is a key driver for the respiratory disease testing market.

The increasing prevalence of tobacco smoking is anticipated to boost the growth of the respiratory disease testing market in the future. Tobacco smoking involves the combustion of dried leaves from the tobacco plant (Nicotiana tabacum) and inhaling the smoke produced. Respiratory disease testing is essential for managing the health of tobacco smokers, as it monitors changes in lung function over time, enabling healthcare professionals to evaluate the success of smoking cessation initiatives and modify treatment plans accordingly. For instance, in September 2024, the Centers for Disease Control and Prevention, a US government agency, reported that tobacco use remains the leading cause of preventable illness and death in the United States. In 2022, around 49.2 million adults, or 19.8%-nearly 1 in 5-indicated they used tobacco products. Consequently, the rising incidence of tobacco smoking is driving the expansion of the respiratory disease testing market.

Technological advancements are emerging as a prominent trend in the respiratory disease testing market, with major companies focusing on innovative solutions to enhance treatment protocols and elevate patient outcomes. A notable example is Respira Labs, a U.S.-based healthcare technology company, which introduced the AI-powered wearable device, Sylvee, in March 2022. Sylvee, worn as a chest strap, employs artificial intelligence and machine learning algorithms to analyze data from multiple sensors measuring breathing rate, volume, and patterns. This device aids in the early diagnosis and management of conditions such as chronic obstructive pulmonary disease (COPD), asthma, and COVID-19, utilizing advanced AI algorithms to analyze breath sounds and provide real-time feedback on lung function.

Major players in the respiratory disease testing market are actively engaged in developing advanced products, such as pulmonary function testing, to establish a competitive advantage. A case in point is Vitalograph Ltd., a UK-based provider of respiratory diagnostics, which launched the VitaloPFT series in March 2023. This series offers detailed pulmonary function testing options, providing healthcare providers with a cost-effective solution for advanced respiratory diagnostics. Its user-friendly design simplifies the testing process, enhancing accessibility for healthcare professionals.

In January 2023, CAIRE Inc., a prominent U.S.-based medical supply and manufacturing company, completed the acquisition of MGC Diagnostics Holdings for an undisclosed amount. This strategic move is driven by CAIRE Inc.'s objective to expand the scope of its product line, diversify its income streams, and fortify its position as a leading player in the medical technology sector, specifically focusing on respiratory and cardiorespiratory diagnostics. MGC Diagnostics Holdings Inc., the acquired entity, is a U.S.-based medical technology company specializing in offering comprehensive cardiorespiratory diagnostic solutions and respiratory disease testing products.

Major companies operating in the respiratory disease testing market include Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Dragerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc., Natus Medical Incorporated

North America was the largest region in the respiratory disease testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in the respiratory disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the respiratory disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The respiratory disease testing market includes revenues earned by entities by providing services such as exhaled nitric oxide tests lung function tests. oxygen therapy, bronchoscopy, ultrasonography, nuclear lung scanning, and pulmonary artery angiography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Disease Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory disease testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Imaging Tests; Mechanical Tests; In-Vitro Diagnostic Tests
• 2) By Products: Lung Volume; Imaging; Spirometry; Peak Flow; Blood Gas; Other Products
• 3) By Application: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis Female; Other Application
• 4) By End-User: Hospitals; Physician clinics; Clinical laboratories; Other End-User
• Subsegments:
• 1) By Imaging Tests: X-rays; Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans
• 2) By Mechanical Tests: Spirometry; Peak Flow Measurement; Lung Volume Measurement; Diffusion Capacity Tests
• 3) By In-Vitro Diagnostic Tests: PCR Tests; Antigen Tests; Antibody Tests; Culture Tests
• Companies Mentioned: Medtronic plc; Abbott Laboratories; Seimens Healthineers AG; Koninklijke Philips N.V.; ResMed Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Disease Testing Market Characteristics

3. Respiratory Disease Testing Market Trends And Strategies

4. Respiratory Disease Testing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Respiratory Disease Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Respiratory Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Respiratory Disease Testing Market Growth Rate Analysis
• 5.4. Global Respiratory Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Respiratory Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Respiratory Disease Testing Total Addressable Market (TAM)

6. Respiratory Disease Testing Market Segmentation

• 6.1. Global Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Tests
• Mechanical Tests
• In-Vitro Diagnostic Tests
• 6.2. Global Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lung Volume
• Imaging
• Spirometry
• Peak Flow
• Blood Gas
• Other Products
• 6.3. Global Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Obstructive Pulmonary Disease
• Lung Cancer
• Asthma
• Tuberculosis Female
• Other Application
• 6.4. Global Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Physician clinics
• Clinical laboratories
• Other End-User
• 6.5. Global Respiratory Disease Testing Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• X-rays
• Computed Tomography (CT) Scans
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET) Scans
• 6.6. Global Respiratory Disease Testing Market, Sub-Segmentation Of Mechanical Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spirometry
• Peak Flow Measurement
• Lung Volume Measurement
• Diffusion Capacity Tests
• 6.7. Global Respiratory Disease Testing Market, Sub-Segmentation Of In-Vitro Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Tests
• Antigen Tests
• Antibody Tests
• Culture Tests

7. Respiratory Disease Testing Market Regional And Country Analysis

• 7.1. Global Respiratory Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Respiratory Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Disease Testing Market

• 8.1. Asia-Pacific Respiratory Disease Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Disease Testing Market

• 9.1. China Respiratory Disease Testing Market Overview
• 9.2. China Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Disease Testing Market

• 10.1. India Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Disease Testing Market

• 11.1. Japan Respiratory Disease Testing Market Overview
• 11.2. Japan Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Disease Testing Market

• 12.1. Australia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Disease Testing Market

• 13.1. Indonesia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Disease Testing Market

• 14.1. South Korea Respiratory Disease Testing Market Overview
• 14.2. South Korea Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Disease Testing Market

• 15.1. Western Europe Respiratory Disease Testing Market Overview
• 15.2. Western Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Disease Testing Market

• 16.1. UK Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Disease Testing Market

• 17.1. Germany Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Disease Testing Market

• 18.1. France Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Disease Testing Market

• 19.1. Italy Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Disease Testing Market

• 20.1. Spain Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Disease Testing Market

• 21.1. Eastern Europe Respiratory Disease Testing Market Overview
• 21.2. Eastern Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Disease Testing Market

• 22.1. Russia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Disease Testing Market

• 23.1. North America Respiratory Disease Testing Market Overview
• 23.2. North America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Disease Testing Market

• 24.1. USA Respiratory Disease Testing Market Overview
• 24.2. USA Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Disease Testing Market

• 25.1. Canada Respiratory Disease Testing Market Overview
• 25.2. Canada Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Disease Testing Market

• 26.1. South America Respiratory Disease Testing Market Overview
• 26.2. South America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Disease Testing Market

• 27.1. Brazil Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Disease Testing Market

• 28.1. Middle East Respiratory Disease Testing Market Overview
• 28.2. Middle East Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Disease Testing Market

• 29.1. Africa Respiratory Disease Testing Market Overview
• 29.2. Africa Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Disease Testing Market Competitive Landscape And Company Profiles

• 30.1. Respiratory Disease Testing Market Competitive Landscape
• 30.2. Respiratory Disease Testing Market Company Profiles
  • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. ResMed Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Disease Testing Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. Becton Dickinson and Company
• 31.3. F. Hoffmann-La Roche Ltd.
• 31.4. Nihon Kohden Corporation
• 31.5. GE HealthCare Technologies Inc.
• 31.6. Fisher & Paykel Healthcare Corporation Limited
• 31.7. Qiagen N.V.
• 31.8. Medical Graphics Corporation
• 31.9. COSMED srl
• 31.10. ndd Medizintechnik AG
• 31.11. Vitalograph Ltd.
• 31.12. MGC Diagnostics Corporation
• 31.13. Vyaire Medical Inc.
• 31.14. Masimo Corporation
• 31.15. Hamilton Medical AG

32. Global Respiratory Disease Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Disease Testing Market

34. Recent Developments In The Respiratory Disease Testing Market

35. Respiratory Disease Testing Market High Potential Countries, Segments and Strategies

• 35.1 Respiratory Disease Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Respiratory Disease Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Respiratory Disease Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer